• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索皂素佐剂在 COVID-19 疫苗中的可能用途。

Exploring the possible use of saponin adjuvants in COVID-19 vaccine.

机构信息

Disease Investigation Laboratory, ICAR-Indian Veterinary Research Institute, Regional Station , Palampur, India.

Division of Pathology, ICAR-Indian Veterinary Research Institute , Bareilly, India.

出版信息

Hum Vaccin Immunother. 2020 Dec 1;16(12):2944-2953. doi: 10.1080/21645515.2020.1833579. Epub 2020 Dec 9.

DOI:10.1080/21645515.2020.1833579
PMID:33295829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7738204/
Abstract

There is an urgent need for a safe, efficacious, and cost-effective vaccine for the coronavirus disease 2019 (COVID-19) pandemic caused by novel coronavirus strain, severe acute respiratory syndrome-2 (SARS-CoV-2). The protective immunity of certain types of vaccines can be enhanced by the addition of adjuvants. Many diverse classes of compounds have been identified as adjuvants, including mineral salts, microbial products, emulsions, saponins, cytokines, polymers, microparticles, and liposomes. Several saponins have been shown to stimulate both the Th1-type immune response and the production of cytotoxic T lymphocytes against endogenous antigens, making them very useful for subunit vaccines, especially those for intracellular pathogens. In this review, we discuss the structural characteristics, mechanisms of action, structure-activity relationship of saponins, biological activities, and use of saponins in various viral vaccines and their applicability to a SARS-CoV-2 vaccine.

摘要

目前迫切需要针对由新型冠状病毒株引起的 2019 年冠状病毒病(COVID-19)大流行的安全、有效且具成本效益的疫苗。佐剂的添加可以增强某些类型疫苗的保护免疫。已鉴定出许多不同类别的化合物作为佐剂,包括矿物盐、微生物产物、乳剂、皂苷、细胞因子、聚合物、微粒和脂质体。一些皂苷已被证明可刺激 Th1 型免疫反应和细胞毒性 T 淋巴细胞针对内源性抗原的产生,使其非常适合亚单位疫苗,特别是针对细胞内病原体的疫苗。在这篇综述中,我们讨论了皂苷的结构特征、作用机制、结构-活性关系、生物活性以及皂苷在各种病毒疫苗中的应用及其在 SARS-CoV-2 疫苗中的适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5645/8641581/f722aeacd558/KHVI_A_1833579_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5645/8641581/0092388cecea/KHVI_A_1833579_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5645/8641581/f722aeacd558/KHVI_A_1833579_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5645/8641581/0092388cecea/KHVI_A_1833579_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5645/8641581/f722aeacd558/KHVI_A_1833579_F0002_OC.jpg

相似文献

1
Exploring the possible use of saponin adjuvants in COVID-19 vaccine.探索皂素佐剂在 COVID-19 疫苗中的可能用途。
Hum Vaccin Immunother. 2020 Dec 1;16(12):2944-2953. doi: 10.1080/21645515.2020.1833579. Epub 2020 Dec 9.
2
A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination.两剂基于重组 S1 蛋白的 COVID-19 疫苗接种为最佳方案。
Virology. 2022 Jan;566:56-59. doi: 10.1016/j.virol.2021.11.011. Epub 2021 Dec 1.
3
A Novel Polymer Nanoparticle Polydimethyl Diallyl Ammonium Chloride as An Adjuvant Enhances the Immune Response of SARS-CoV-2 Subunit Vaccine.一种新型聚合物纳米粒子聚二甲基二烯丙基氯化铵作为佐剂增强了 SARS-CoV-2 亚单位疫苗的免疫反应。
Adv Healthc Mater. 2024 Jun;13(15):e2304575. doi: 10.1002/adhm.202304575. Epub 2024 Mar 10.
4
Advances in saponin-based adjuvants.基于皂苷的佐剂的进展。
Vaccine. 2009 Mar 13;27(12):1787-96. doi: 10.1016/j.vaccine.2009.01.091. Epub 2009 Feb 7.
5
Carbohydrate-containing nanoparticles as vaccine adjuvants.含碳水化合物的纳米颗粒作为疫苗佐剂。
Expert Rev Vaccines. 2021 Jul;20(7):797-810. doi: 10.1080/14760584.2021.1939688. Epub 2021 Jun 15.
6
Saponins from the Spanish saffron Crocus sativus are efficient adjuvants for protein-based vaccines.西班牙藏红花(Crocus sativus)中的皂苷是蛋白质疫苗的有效佐剂。
Vaccine. 2012 Jan 5;30(2):388-97. doi: 10.1016/j.vaccine.2011.10.080. Epub 2011 Nov 10.
7
Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses.皂苷纳米颗粒佐剂结合 Toll 样受体激动剂可诱导不同的免疫特征和有效的疫苗应答。
Sci Adv. 2024 Aug 9;10(32):eadn7187. doi: 10.1126/sciadv.adn7187. Epub 2024 Aug 7.
8
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.严重急性呼吸综合征冠状病毒2型刺突-FLIPr融合蛋白加脂化FLIPr可保护仓鼠免受多种严重急性呼吸综合征冠状病毒2型变体的侵害。
J Virol. 2024 Feb 20;98(2):e0154623. doi: 10.1128/jvi.01546-23. Epub 2024 Feb 1.
9
Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.巴西苏木叶皂素增强牛病毒性腹泻病毒实验疫苗的长期特异性免疫应答并促进剂量节约效应。
Vaccine. 2018 Jan 2;36(1):55-65. doi: 10.1016/j.vaccine.2017.11.030. Epub 2017 Nov 23.
10
Lipid Nanoparticle with 1,2-Di-O-octadecenyl-3-trimethylammonium-propane as a Component Lipid Confers Potent Responses of Th1 Cells and Antibody against Vaccine Antigen.作为一种组成脂质的 1,2-二油烯基-3-三甲铵丙烷脂质纳米颗粒赋予了 Th1 细胞强烈的反应和针对疫苗抗原的抗体。
ACS Nano. 2024 Jul 2;18(26):16589-16609. doi: 10.1021/acsnano.4c00278. Epub 2024 Jun 17.

引用本文的文献

1
RNA sequencing analysis reveals as the key regulator in response to methyl jasmonate-induced saponin accumulation in .RNA测序分析表明,[具体内容缺失]是[具体植物名称缺失]中响应茉莉酸甲酯诱导的皂苷积累的关键调节因子。
Hortic Res. 2024 Feb 28;11(5):uhae058. doi: 10.1093/hr/uhae058. eCollection 2024 May.
2
Potential Immunoregulatory Mechanism of Plant Saponins: A Review.植物皂素的潜在免疫调节机制:综述。
Molecules. 2023 Dec 23;29(1):113. doi: 10.3390/molecules29010113.
3
The Utilization of Plant-Material-Loaded Vesicular Drug Delivery Systems in the Management of Pulmonary Diseases.

本文引用的文献

1
A comparative analysis of saponin-enriched fraction from (Moench) Garcke, (Gaertn) and (Santapau and Fernandes): an hemolytic and cytotoxicity evaluation.比较分析 (Moench)Garcke、 (Gaertn)和 (Santapau 和 Fernandes)中皂苷富集部分:溶血和细胞毒性评价。
Anim Biotechnol. 2022 Feb;33(1):193-199. doi: 10.1080/10495398.2020.1775627. Epub 2020 Jun 17.
2
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines.新型冠状病毒肺炎(COVID-19)——新型疫苗候选物的最新研究进展和即将面世的 SARS-CoV-2 疫苗的现状。
Hum Vaccin Immunother. 2020 Dec 1;16(12):2891-2904. doi: 10.1080/21645515.2020.1788310. Epub 2020 Jul 23.
3
植物材料负载的囊泡药物递送系统在肺部疾病治疗中的应用
Curr Issues Mol Biol. 2023 Dec 12;45(12):9985-10017. doi: 10.3390/cimb45120624.
4
Immunization with recombinant LiHyp1 protein plus adjuvant is protective against tegumentary leishmaniasis.用重组 LiHyp1 蛋白加佐剂进行免疫接种可预防皮肤利什曼病。
Parasitol Res. 2023 Dec;122(12):2917-2931. doi: 10.1007/s00436-023-07981-6. Epub 2023 Sep 28.
5
Shatavarin-IV saponin adjuvant elicits IgG and IgG2b responses against bacterin in a murine model.印度人参-IV皂苷佐剂在小鼠模型中引发针对菌苗的IgG和IgG2b应答。
Heliyon. 2023 Apr 11;9(4):e15339. doi: 10.1016/j.heliyon.2023.e15339. eCollection 2023 Apr.
6
Inhibiting Angiogenesis by Anti-Cancer Saponins: From Phytochemistry to Cellular Signaling Pathways.抗癌皂苷抑制血管生成:从植物化学到细胞信号通路
Metabolites. 2023 Feb 22;13(3):323. doi: 10.3390/metabo13030323.
7
Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era.皂苷:研究进展及其在新冠疫情后时代的潜在作用
Pharmaceutics. 2023 Jan 20;15(2):348. doi: 10.3390/pharmaceutics15020348.
8
Development and Evaluation of a Novel Diammonium Glycyrrhizinate Phytosome for Nasal Vaccination.用于鼻腔接种的新型甘草酸二铵磷脂复合物的研发与评价
Pharmaceutics. 2022 Sep 21;14(10):2000. doi: 10.3390/pharmaceutics14102000.
9
Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity.基于重组 RBD/N 蛋白和皂苷佐剂的重组 COVID-19 疫苗诱导持久的中和抗体和细胞免疫。
Front Immunol. 2022 Sep 8;13:974364. doi: 10.3389/fimmu.2022.974364. eCollection 2022.
10
Disruption of Colorectal Cancer Network by Polyphyllins Reveals Pivotal Entities with Implications for Chemoimmunotherapy.重楼属植物对结直肠癌网络的破坏揭示了对化学免疫疗法有影响的关键实体。
Biomedicines. 2022 Mar 2;10(3):583. doi: 10.3390/biomedicines10030583.
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates.
重组 SARS-CoV-2 刺突 S1-Fc 融合蛋白在非人灵长类动物中诱导了高水平的中和反应。
Vaccine. 2020 Jul 31;38(35):5653-5658. doi: 10.1016/j.vaccine.2020.06.066. Epub 2020 Jun 24.
4
Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective.冠状病毒病大流行(COVID-19):挑战与全球视角
Pathogens. 2020 Jun 28;9(7):519. doi: 10.3390/pathogens9070519.
5
Coronavirus Disease 2019-COVID-19.新型冠状病毒肺炎。
Clin Microbiol Rev. 2020 Jun 24;33(4). doi: 10.1128/CMR.00028-20. Print 2020 Sep 16.
6
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses.针对新兴致病性人类冠状病毒的亚单位疫苗
Front Microbiol. 2020 Feb 28;11:298. doi: 10.3389/fmicb.2020.00298. eCollection 2020.
7
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.COVID-19,一种新兴的冠状病毒感染:在疫苗、免疫疗法和治疗药物的设计和开发方面的进展和前景。
Hum Vaccin Immunother. 2020 Jun 2;16(6):1232-1238. doi: 10.1080/21645515.2020.1735227. Epub 2020 Mar 18.
8
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒:将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.
9
Will novel virus go pandemic or be contained?新型病毒会大流行还是会得到控制?
Science. 2020 Feb 7;367(6478):610-611. doi: 10.1126/science.367.6478.610.
10
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies.一种在中国武汉引发肺炎疫情的新型冠状病毒:呼吁制定治疗和预防策略。
Emerg Microbes Infect. 2020 Jan 31;9(1):275-277. doi: 10.1080/22221751.2020.1723441. eCollection 2020.